WANG Fang, CHEN Ying, LEI Huibin, ZHANG Huifeng, HE Jie, LI Meng, LEI Ting, ZHANG Wei. Clinical Application of Follicular Unit Extraction in Androgenetic Alopecia[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(4): 808-813. DOI: 10.12290/xhyxzz.2022-0716
Citation: WANG Fang, CHEN Ying, LEI Huibin, ZHANG Huifeng, HE Jie, LI Meng, LEI Ting, ZHANG Wei. Clinical Application of Follicular Unit Extraction in Androgenetic Alopecia[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(4): 808-813. DOI: 10.12290/xhyxzz.2022-0716

Clinical Application of Follicular Unit Extraction in Androgenetic Alopecia

Funds: 

Natural Science Basic Research Program of Shaanxi Province in 2021 2021JQ-784

Shaanxi Science and Technology Program of Xi'an City in Shaanxi Province 21YXYJ0129

Shaanxi Science and Technology Office and Development 2022JM-528

University-level Scientific Research Innovation Team of Medical College in 2021 2021TD14

More Information
  • Corresponding author:

    ZHANG Wei, E-mail:doctorzhw@163.com

  • Received Date: December 14, 2022
  • Accepted Date: February 08, 2023
  • Issue Publish Date: July 29, 2023
  •   Objective  To explore the clinical application of follicular unit extraction (FUE) hair transplantation in male androgen alopecia (AGA).
      Methods  From August 2016 to September 2018, male AGA patients operated with FUE hair transplantation in the First Affiliated Hospital of Xi'an Medical University were retrospectively analyzed.At one year after transplantation, clinical curative effect was evaluated by the survival hair density and follicles rate of FUE transplantation, meanwhile surgical complications, patient satisfaction rate and life quality score were measured and analyzed.
      Results  A total of 126 male AGA patients who met the inclusion and exclusion criteria were included, with average age was (37±9.05) years and average disease course was (10±2.76) years.According to the Hamilton-Norwood grade standard, there were 5 grade Ⅱpatients, 55 grade Ⅲ patients, 54 grade Ⅳ patients, 10 grade Ⅴ patients, and 2 grade Ⅵ patients.At one year after transplantation, viable hair density on the anterior hairline and the top of the head was (65±7) FUs/cm2 and (43±4) FUs/cm2, respectively.The survival rate of hair follicles was more than 90%, even more than 95% among the 107 AGA patients.The effective rate was 100%(126/126), no serious complications occurred, and the satisfaction rate of patients was 97.6%(123/126).Besides, the scores of physical function, psychological function, social function and material life status of 126 AGA patients were significantly increased than those before transplantation (all P < 0.01).
      Conclusions  FUE hair transplantation has significant clinical effect, and is highly safe and effective.With the potential to dramatically improve life quality, it can be widely applied in treatment of AGA.
  • [1]
    中国医师协会美容与整形医师分会毛发整形美容专业委员会. 中国人雄激素性脱发诊疗指南[J]. 中国美容整形外科杂志, 2019, 30: 前插2-6. DOI: 10.3969/j.issn.1673-7040.2019.01.001
    [2]
    Gupta AK, Venkataraman M, Talukder M, et al. Relative Efficacy of Minoxidil and the 5-α Reductase Inhibitors in Androgenetic Alopecia Treatment of Male Patients: A Network Meta-analysis[J]. JAMA Dermatol, 2022, 158: 266-274. DOI: 10.1001/jamadermatol.2021.5743
    [3]
    Zhao Z, Tian Q, Zhang B. Effects of rehabilitation nursing care on deep vein thrombosis of the lower limbs following spinal fractures[J]. Am J Transl Res, 2021, 13: 1877-1883.
    [4]
    尹梓贻, 曹国荣, 刘举利, 等. 瘢痕性秃发实施高密度毛发移植技术的治疗效果研究[J]. 中国医疗美容杂志, 2019, 9: 27-31. https://www.cnki.com.cn/Article/CJFDTOTAL-YLMR201905008.htm
    [5]
    Ghonemy S, Alarawi A, Bessar H. Efficacy and safety of a new 10% topical minoxidil versus 5% topical minoxidil and placebo in the treatment of male androgenetic alopecia: a trichoscopic evaluation[J]. J Dermatolog Treat, 2021, 32: 236-241. DOI: 10.1080/09546634.2019.1654070
    [6]
    张阳冰. 男性雄激素性脱发的BASP分型及疗效分析[D]. 广东. 广州医科大学, 2018.
    [7]
    赵钧, 周圳滔, 张菊芳, 等. 毛发移植技术重建发际线的临床研究进展[J]. 组织工程与重建外科杂志, 2020, 16: 260-262. DOI: 10.3969/j.issn.1673-0364.2020.03.022
    [8]
    Gan YY, Du LJ, Hong WJ, et al. Theoretical basis and clinical practice for FUE megasession hair transplantation in the treatment of large area androgenic alopecia[J]. J Cosmet Dermatol, 2021, 20: 210-217. DOI: 10.1111/jocd.13432
    [9]
    Edoardo R, Giorgia C. Scalp Surgery: Quantitative Analysis of Follicular Unit Growth[J]. Plast Reconstr Surg Glob Open, 2015, 3: e539. DOI: 10.1097/GOX.0000000000000524
    [10]
    Vasudevan B, Neema S, Ghosh K, et al. Hair transplanta-tion by follicular unit extraction for male androgenetic alopecia: A retrospective observational study from two centers[J]. Med J Armed Forces India, 2020, 76: 430-437. DOI: 10.1016/j.mjafi.2019.11.001
    [11]
    Garg AK, Garg S. Donor harvesting: follicular unit excision[J]. J Cutan Aesthet Surg, 2018, 11: 195-201. DOI: 10.4103/JCAS.JCAS_123_18
    [12]
    张宝良, 施耘, 曹丽红, 等. 毛发移植发展现状[J]. 国际生物医学工程杂志, 2020, 43: 80-85. https://www.cnki.com.cn/Article/CJFDTOTAL-YLMR202007019.htm
    [13]
    Nadimi S. Complications with Hair Transplantation[J]. Facial Plast Surg Clin North Am, 2020, 28: 225-235. DOI: 10.1016/j.fsc.2020.01.003
    [14]
    Chen HA, Pan JY, Chiang CH, et al. New idea for hair transplantation to preserve more donor hair follicles[J]. Med Hypotheses, 2019, 128: 83-85. DOI: 10.1016/j.mehy.2019.05.018
    [15]
    邱月棨, 付思祺, 罗帅寒天, 等. 2020年雄激素性脱发的研究进展[J]. 中华皮肤科杂志, 2021, 54: 835-838.
    [16]
    Umar S, Shitabata P, Rose P, et al. A New Universal Follicular Unit Excision Classification System for Hair Transplantation Difficulty and Patient Outcome[J]. Clin Cosmet Investig Dermatol, 2022, 15: 1133-1147. DOI: 10.2147/CCID.S369346
    [17]
    Jimenez F, Alam M, Vogel JE, et al. Hair transplantation: Basic overview[J]. J Am Acad Dermatol, 2021, 85: 803-814. DOI: 10.1016/j.jaad.2021.03.124
    [18]
    苗勇, 朱德聪, 樊哲祥, 等. 移植胡须毛囊单位治疗男性雄激素性脱发[J]. 中华整形外科杂志, 2020, 36: 606-611. DOI: 10.3760/cma.j.cn114453-20200407-00203
  • Related Articles

    [1]QU Jinghan, LIU Xin, TIAN Xin, AN Pengjiao, XU Tingting, ZHANG Bo. Comprehensive Clinical Evaluation of Nusinersen Based on Multi-criteria Decision Analysis Method[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(5): 1083-1090. DOI: 10.12290/xhyxzz.2024-0082
    [2]LIU Qingyang, LIU Xin, WANG Shaohong, SHANG Junmei, TANG Yan, ZHANG Bo. Research of Accessibility of Rare Disease Drugs Based on the China's First List of Rare Diseases[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(6): 1208-1216. DOI: 10.12290/xhyxzz.2023-0163
    [3]ZHANG Lu, LI Jian. Castleman Disease in China: State-of-the-art Technology Before the Era of IL-6 Targeted Therapy[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(5): 911-914. DOI: 10.12290/xhyxzz.2023-0227
    [4]ZHOU Qi, LI Qinyuan, LIU Yali, LUO Zhengxiu, ZHANG Weishe, CHEN Tong, LI Guobao, SHANG Hongcai, YANG Kehu, ZHANG Bo, CHEN Yaolong, ZHANG Shuyang. The Development of Guidelines for Rare Diseases: Past, Present and Future[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(3): 621-628. DOI: 10.12290/xhyxzz.2022-0360
    [5]SUN Yajia, SHI Qianling, YANG Nan, GUO Qiangqiang, SU Renfeng, CHEN Ze, ZHANG Guangxin, CAO Xichao, CHEN Yaolong. Rethinking and Exploring the Comprehensive Evaluation of Clinical Practice Guidelines[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(1): 22-30. DOI: 10.12290/xhyxzz.2022-0612
    [6]CHEN Chen, HAN Xiaohong. Clinical Trials of Rare Diseases in China over One Decade: Based on the Chinese First List of Rare Diseases[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(6): 1028-1035. DOI: 10.12290/xhyxzz.2022-0010
    [7]LIU Yuan, ZHAO Lin. Update and Interpretation of 2022 National Comprehensive Cancer Network Clinical Practice Guidelines for Gastric Cancer[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(6): 999-1004. DOI: 10.12290/xhyxzz.2022-0271
    [8]ZHAO Zhe, TANG Yan, ZHOU Jingya, CHEN Xiaoguang, ZHANG Lei, CHEN Limeng, YUAN Tao. Analysis of Clinical Manifestations and Drug Therapies of Gitelman Syndrome[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(2): 277-286. DOI: 10.12290/xhyxzz.2021-0180
    [9]YU Songlin, WANG Danchen, ZOU Yutong, MA Xiaoli, QIU Ling. The Clinical Application of Liquid Chromatography-Tandem Mass Spectrometry in the Diagnosis of Rare Diseases[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(4): 450-455. DOI: 10.12290/xhyxzz.2021-0324
    [10]Shi CHEN, Xi BAI, Hui PAN, Hui-juan ZHU. Training of Clinical Thinking about Rare Diseases from a Case of Hypothalamic and Pituitary Mass[J]. Medical Journal of Peking Union Medical College Hospital, 2020, 11(3): 343-346. DOI: 10.3969/j.issn.1674-9081.20200057
  • Cited by

    Periodical cited type(13)

    1. 戴泽琦,景城阳,吴雪,张乐,廖星. 基于EVIDEM框架的中成药临床综合评价指标体系构建及解读. 中国实验方剂学杂志. 2024(06): 134-143 .
    2. 戴宁,何青鋆,陆芳. 近十年国内药品临床综合评价研究的现状分析与建议. 中医杂志. 2024(04): 357-361 .
    3. 程瑶瑶,宋沧桑,李兴德,刘璐,邓雨琴,毛盼盼. 基于真实世界数据的药品临床综合评价研究进展. 中南药学. 2024(02): 473-476 .
    4. 鲁乔丹,王欢,马玉芬,邓海波,徐园,王磊. 《静脉血栓栓塞症核心结局指标集》解读. 中华现代护理杂志. 2024(08): 989-996 .
    5. 王珺琦,殷悦,唐文熙. 医保准入视角下罕见病用药经济价值评估的难点、方法与建议. 卫生经济研究. 2024(09): 58-61 .
    6. 屈静晗,刘鑫,田欣,安鹏姣,许婷婷,张波. 基于多准则决策分析方法的诺西那生临床综合评价. 协和医学杂志. 2024(05): 1083-1090 . 本站查看
    7. 潘欢妍,蔡俊,王倩,盛梦迪,李俐. 多准则决策分析在药品管理领域中的应用研究进展. 中南药学. 2023(02): 477-481 .
    8. 黄桂新,曾航齐,张武军. 基于多准则的医疗大数据智能决策平台模型构建探索. 中国数字医学. 2023(01): 53-57 .
    9. 董艳珍,宋沧桑,李兴德,刘璐. 集中带量采购政策下的药品临床综合评价研究进展. 中南药学. 2023(05): 1388-1392 .
    10. 杨雪,李晨,蔡永青,鲜秋婉,幸海燕. 药品临床综合评价思维在医院药品临时采购管理中的应用实践. 中国药房. 2023(10): 1172-1176 .
    11. 戴泽琦,景城阳,吴雪,张乐,廖星. 国内外药品临床综合评价指标体系研究的系统评价. 中国循证医学杂志. 2023(07): 776-782 .
    12. 中华检验医学培训工程专家委员会,中华医学会呼吸病学分会. 成人呼吸道感染病原诊断核酸检测技术临床应用专家共识(2023). 协和医学杂志. 2023(05): 959-971 . 本站查看
    13. 徐英春,胡继红. 新型冠状病毒抗原快速检测专家共识(2022). 协和医学杂志. 2022(03): 402-411 . 本站查看

    Other cited types(3)

Catalog

    Article Metrics

    Article views (321) PDF downloads (47) Cited by(16)
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return
    x Close Forever Close